References
- Berger B, Stenström G, Sundkvist G. Incidence, prevalence, and mortality of diabetes in a large population: A report from the Skaraborg Diabetes Registry. Diabetes Care 1999; 22:773–78.
- Jansson SP, Andersson DK, Svardsudd K. Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up. Diabetologia 2007;50: 703–10.
- Thunander M, Petersson C, Jonzon K, Fornander J, Ossiansson B, Törn C, . Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res Clin Pract 2008;82:247–55.
- Lindahl B, Stenlund H, Norberg M. Increasing glucose concentrations and prevalence of diabetes mellitus in northern Sweden, 1990–2007. Glob Health Action 2010;3. doi: 10.3402/gha.v3i0.5222.
- Wautier JL, Guillausseau PJ. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab 2001;27:535–42.
- Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 2002;287:2570–81.
- Fu AZ, Qiu Y, Radican L, Wells BJ. Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care 2009;32: 2187–92.
- Norberg M, Wall S, Boman K, Weinehall L. The Vasterbotten Intervention Programme: Background, design and implications. Glob Health Action 2010;3: doi:10.3402/gha.v3i0. 4643.
- Hallmans G, Agren A, Johansson G, Johansson A, Stegmayr B, Jansson JH, . Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort: Evaluation of risk factors and their interactions. Scand J Public Health 2003;61(Suppl):18–24.
- Sundquist K, Chaikiat A, Ramirez Leon V, Johansson SE, Sundquist J. Country of birth, socioeconomic factors and risk factor control in patients with type 2 diabetes: A Swedish study from 25 primary health care centers. Diabetes Metab Res Rev 2011;27:244–54.
- Eriksson CG, Granvik M, Kindblad I, Lindgren G, Nystrom L, Rosen M, . Health problems in a Swedish county: What can we learn from official sources? Soc Sci Med C 1981;15:143–51.
- Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539–53.
- Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993;42: 359–62.
- Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, . Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 2005;48: 2206–12.
- Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, . Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151–56.
- Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, . A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994;37:344–50.
- Falorni A, Ortqvist E, Persson B, Lernmark A. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Methods 1995;186:89–99.
- Daka B, Svensson MK, Lernmark Å, Mincheva-Nilsson L, Hallmans G, Rolandsson O. Low agreement between radio binding assays in analyzing glutamic acid decarboxylase (GAD65Ab) autoantibodies in patients classified with type 2 diabetes. Autoimmunity 2009;42:1–8.
- Britt H, Angelis M, Harris E. The reliability and validity of doctor-recorded morbidity data in active data collection systems. Scand J Prim Health Care 1998;16:50–5.
- Mansson J, Nilsson G, Bjorkelund C, Strender LE. Collection and retrieval of structured clinical data from electronic patient records in general practice: A first-phase study to create a health care database for research and quality assessment. Scand J Prim Health Care 2004;22: 6–10.
- Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, . UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997;350:1288–93.
- Rolandsson O, Palmer JP. Latent autoimmune diabetes in adults (LADA) is dead: Long live autoimmune diabetes! Diabetologia 2010;53:1250–53.